Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?

Rhea-AI Summary

{"summary":"","positive":[],"negative":[],"faq":[]}

News Market Reaction – MASI

-0.01%

1 alert

-0.01% News Effect

On the day this news was published, MASI declined 0.01%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Masimo deal price: $180.00 per share Arcellx cash price: $115.00 per share Arcellx CVR: $5.00 per share +2 more

5 metrics

Masimo deal price $180.00 per share Cash consideration in sale to Danaher

Arcellx cash price $115.00 per share Cash component in sale to Gilead for ACLX holders

Arcellx CVR $5.00 per share Contingent value right tied to milestones for ACLX

Great Lakes deal price $17.00 per share Cash consideration in sale of GLDD to Saltchuk

Current MASI price $175.49 Price before this shareholder‑rights headline

Market Reality Check

Price: $178.70 Vol: Volume 544,720 is well be...

low vol

$178.70 Last Close

Volume Volume 544,720 is well below 20-day average 2,864,570 (relative volume 0.19). low

Technical Price $175.49 is trading above the 200-day MA at $150.48 and just below the agreed $180 deal price.

Peers on Argus

Peer medical device names like GMED, BIO, IRTC, GKOS, and BRKR show declines of ...

Peer medical device names like GMED, BIO, IRTC, GKOS, and BRKR show declines of about 0.7–1.2%, while MASI is nearly flat at -0.01%, indicating a more company-specific setup rather than a broad sector move.

Historical Context

5 past events · Latest: Feb 24 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Feb 24	Shareholder investigation	Neutral	-0.1%	Law firm review of deal terms and potential shareholder remedies.
Feb 17	Acquisition agreement	Positive	+34.2%	Danaher agreement to acquire Masimo for $180 per share in cash.
Feb 17	Acquisition valuation	Positive	+34.2%	Details on deal valuation metrics and expected synergies from Danaher.
Feb 12	Earnings date notice	Neutral	-1.5%	Announcement of timing for Q4 and full‑year 2025 financial results.
Jan 12	Prelim financials	Positive	-4.8%	Preliminary 2025 revenue and non‑GAAP EPS tracking at high end of guidance.

Pattern Detected

Takeout news on Feb 17 triggered a strong positive move, while earlier positive preliminary results in January saw a negative reaction, suggesting some inconsistency in how fundamentally good news was priced versus strategic/M&A developments.

Recent Company History

Over the past few months, Masimo’s story has been dominated by acquisition activity. On Feb 17, Danaher agreed to acquire Masimo for $180 per share, with related announcements both coinciding with a +34.22% move. Prior to that, Masimo released preliminary 2025 results on Jan 12 showing higher revenue and non‑GAAP EPS expectations, yet the stock fell 4.82%. Routine items like earnings date notices and prior law firm investigations around deal fairness had modest price impacts, framing today’s similar shareholder‑rights headline against an already established M&A backdrop.

Market Pulse Summary

This announcement highlights a law firm’s investigation into whether Masimo’s agreed sale to Danaher...

Analysis

This announcement highlights a law firm’s investigation into whether Masimo’s agreed sale to Danaher for $180 per share offers fair value to shareholders, similar to prior inquiries seen after the deal was disclosed. Recent history shows Masimo driven largely by this transaction, with a +34.22% move on the original announcement and earlier preliminary 2025 results indicating solid growth. Investors may watch for any changes to deal terms, regulatory milestones, and the scheduled full 2025 results release when assessing the evolving risk‑reward profile.

Key Terms

contingent value right, fiduciary duties, federal securities laws, contingent fee basis

4 terms

contingent value right financial

"plus one contingent value right of $5.00 per share upon the achievement..."

A contingent value right is a special security that gives its holder the right to receive one or more future payments only if specified events happen, such as a product reaching a sales target or getting regulatory approval. It matters to investors because it offers potential extra payout tied to uncertain outcomes—like a bet that a project will succeed—so it can add upside to a deal while also carrying extra risk and valuation uncertainty.

fiduciary duties regulatory

"potential violations of the federal securities laws and/or breaches of fiduciary duties..."

Fiduciary duties are the legal and ethical responsibilities that company directors, officers, or financial advisors have to put shareholders’ interests ahead of their own, acting with honesty, care, and loyalty. Think of it like a guardian managing someone’s money: choices must prioritize the owner’s benefit, avoid conflicts, and be made with prudent judgment; investors rely on these duties to ensure decisions aren’t self‑serving and to provide grounds for legal action if abused.

federal securities laws regulatory

"potential violations of the federal securities laws and/or breaches of fiduciary..."

Federal securities laws are the set of national rules that require companies and market participants to provide accurate information, prohibit deceptive practices, and ensure fair trading of stocks and bonds. Think of them as the rules of the road for financial markets: they help investors make informed choices by mandating disclosures and punishing fraud, which reduces risk and builds trust in the safety and reliability of investments.

contingent fee basis financial

"We would handle any matter on a contingent fee basis, whereby you would not..."

A contingent fee basis is an arrangement where payment is made only if a specified outcome is achieved, like a lawyer getting paid only when a lawsuit succeeds or a finder receiving a commission only if a deal closes. For investors, it matters because contingent obligations shift risk off the payer and onto the payee, can reduce upfront costs but create future liabilities or incentives that affect valuations and the alignment of interests — think of it as a “pay-if-success” bet on a specific result.

AI-generated analysis. Not financial advice.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

The proposed transactions may contain terms that could limit superior competing offers.

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

NEW YORK, March 16, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Masimo Corporation (NASDAQ: MASI)'s sale to Danaher Corporation for $180.00 per share in cash. If you are a Masimo shareholder, click here to learn more about your legal rights and options.

Arcellx, Inc. (NASDAQ: ACLX)'s sale to Gilead Sciences, Inc. for $115.00 per share in cash plus one contingent value right of $5.00 per share upon the achievement of certain milestones. If you are an Arcellx shareholder, click here to learn more about your legal rights and options.

Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD)'s sale to Saltchuk Resources, Inc. for $17.00 per share in cash. If you are a Great Lakes shareholder, click here to learn more about your rights and options.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/are-masi-aclx-gldd-obtaining-fair-deals-for-their-shareholders-302714560.html

SOURCE Halper Sadeh LLP